Ipsos Reports Share and Voting Rights for September 2025
Monthly Update on Shares and Voting Rights
In a noteworthy update, Ipsos recently disclosed the total number of shares and voting rights as of the end of September 2025. This timely announcement provides valuable insights into the company's shareholder structure and overall governance.
Key Figures Overview
As of September 30, 2025, the total number of shares issued by Ipsos stood at 43,203,225. This figure reflects the company's robust standing in the market, ensuring transparency for all stakeholders. Additionally, the voting rights associated with these shares include:
Theoretical Voting Rights
The theoretical voting rights, which calculate the number of voting rights attached to all shares, including those with suspended voting rights, reached 48,979,191. This metric is critical as it highlights the potential influence of shareholders in the company's decision-making processes.
Exercisable Voting Rights
On the other hand, the number of exercisable voting rights was reported at 48,925,369. These figures play a significant role in corporate governance, indicating the actual voting power available to shareholders, excluding shares that do not confer voting rights.
Understanding Voting Rights
This information is crucial, as it shows how many shares actively participate in corporate governance matters. The different categories of voting rights help clarify the company's approach to stakeholder engagement. The calculation of these rights is governed by Article 223-11 of the AMF general regulation, which aims to ensure accurate reports on shareholder influence.
Further Information Access
For those interested in more extensive details, Ipsos provides this information in the "Regulated Information" section on its website. This commitment to transparency enables shareholders and potential investors to stay informed about their investments.
Frequently Asked Questions
1. What was the total number of shares reported by Ipsos?
As of September 30, 2025, Ipsos reported a total of 43,203,225 shares.
2. How many theoretical voting rights did Ipsos have?
The theoretical voting rights amounted to 48,979,191, including shares with suspended rights.
3. What are exercisable voting rights, and how many does Ipsos have?
Exercisable voting rights denote the votes shareholders can actually cast, totaling 48,925,369 for Ipsos.
4. Why is the distinction between theoretical and exercisable voting rights important?
This distinction is crucial as it differentiates between possible and actual shareholder influence in corporate governance.
5. Where can I find more information about Ipsos' regulatory disclosures?
More details are available on the "Regulated Information" section of Ipsos' official website, which provides comprehensive updates for stakeholders.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.